Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK. - Wikidata - awgldk - TriplyDB

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

http://www.wikidata.org/entity/Q37871569

about

A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway Soluble TNF-Like Weak Inducer of Apoptosis as a New Marker in Preeclampsia: A Pilot Clinical Study.TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.Recent advances in proteomic technologies applied to cardiovascular disease.Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.The association of high sCD163/sTWEAK ratio with cardiovascular disease in hemodialysis patients.Reduced circulating levels of TWEAK are associated with gestational diabetes mellitus.

P2860

Q28729829-A78B1E85-03E8-47D7-88B9-7FD70C86A173 Q36637472-715984E3-DD62-4ADC-BE7D-86709F3F0931 Q37494039-09440B60-079E-4546-995B-18F45D86C69F Q38034137-5BC4BD3C-63AC-4E58-B54C-C2F07419C25C Q38106664-96C876F6-6E8C-4A2F-B2E2-86D94AB3567B Q38552059-6DC52661-5B17-46EA-8F68-1882768C8520 Q38638020-C5F886C2-18D0-44BD-B320-6204F6FF9D37 Q40470226-ECE85AC0-F261-485E-8ABC-B9C699A67863 Q50456399-391D6A2F-457F-4ED3-BB65-3E67E0FFBBDF

P2860

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

http://www.wikidata.org/entity/Q37871569

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

@en

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

@nl

type

label

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

@en

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

@nl

prefLabel

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

@en

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

@nl

P1433

Q37871569-4270D1B9-B1AF-499F-A86A-C1AC21C147CE

P1476

Q37871569-6138F0D3-A08E-4D48-BBD5-3EB081D1732A

P2093

Q37871569-6867BE2C-26BE-4A1E-BDF2-6EDD16E15C9A

Q37871569-9F5CD701-E865-41AD-838E-81B038EEB270

Q37871569-CF0EC28A-391B-4330-A490-8D7FC7ADD6D8

P2860

Q37871569-0041F3CC-3E47-4BFC-9C2B-40CDFF27C32F

Q37871569-0FCB0743-2F98-49F2-B7EF-2DFAC5E4D9D5

Q37871569-1A429A5B-C55F-4805-8682-6655916D4CD1

Q37871569-1D3150BE-5716-416C-83F7-9EBFB54D0AF3

Q37871569-27F3E35B-2F7C-41B4-9EC8-376BEE084EA8

Q37871569-2ABE53E1-09FE-4A11-91DA-6ABE46D5DD8E

Q37871569-2C09C258-4321-44E0-8122-1608F9530BD3

Q37871569-301987FB-DDD3-4498-8F16-69DF93025EBB

Q37871569-35EC078C-E50C-459F-9C77-9DDCDFD7BCEF

Q37871569-38206125-E2CB-4A68-8F6E-0129BD72D313

P304

Q37871569-AFC024E3-C760-42E5-8DA5-F27CB00DD49A

P31

Q37871569-30B98BBC-C8C6-446F-9A9C-3E46E78ACA93

P356

Q37871569-F63F1E4A-185C-4EE4-A08E-52E2BFD93CF5

P433

Q37871569-812A5189-C407-466F-BB61-13D2B9DAE32A

P478

Q37871569-51E6911A-8157-4CF4-BA8B-A80B5B6C12E4

P50

Q37871569-45C02409-A139-4F81-B664-6E44CDCE60D4

Q37871569-67619AB0-D42E-45F1-B19F-F9416BF8B068

Q37871569-87CAAC83-EB96-4635-A86C-EA913F5B4386

Q37871569-A1982B6E-DDAC-4B6E-A0FA-73488CF2E6C7

Q37871569-AF57B40C-6D1D-413E-8E0F-FE388099DD66

P577

Q37871569-C660573A-399C-4CE9-AA3D-E490602D1C30

P5875

Q37871569-E78AE76F-F20B-435D-8874-BFCD31767D8A

P698

Q37871569-DCD6DBF4-9AAE-405B-BBB4-B0FC2C71022B

P921

Q37871569-C1361BFF-196C-48E4-BC12-BF9805439278

P356

P1433

Proteomics - Clinical Applications

P1476

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

@en

P2093

Carmen Gómez-Guerrero

http://www.w3.org/2001/XMLSchema#string

Jesús Egido

http://www.w3.org/2001/XMLSchema#string

Mahmut I Yilmaz

http://www.w3.org/2001/XMLSchema#string

P2860

Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia

Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

Inflammation and atherosclerosis

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis.

Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study

Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation

P304

281-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRCA.201000102

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Luis M Blanco-Colio

Jose L Martín-Ventura

P577

2011-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51094853

http://www.w3.org/2001/XMLSchema#string

P698

21538911

http://www.w3.org/2001/XMLSchema#string

P921